AxoSim

Prediction

AxoSim's Nerve-on-a-Chip® platform is the only in vitro solution to enable the clinically-relevant measurement of nerve conduction velocity.
Correlation

Our unique tissue-engineering approach to 3D human cell models allows for histomorphometry to correlate with functional metrics.
Efficiency

Achieve the predictive readouts critical to your R&D success in a matter of weeks and at a fraction of the cost of in vivo studies.

PLATFORM

How it works

AxoSim's Nerve-on-a-Chip™ platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.

News

AxoSim receives NIH grant...

AxoSim, a startup that was spun out of Tulane University, has received a $1,770,000 grant over two years to advance their Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing. The grant...

Read Full Article

Axosim hiring scientists

Up-and-Coming AxoSim Hiring Scientists After Landing Research Grants to Speed Research. AxoSim, a biotech company headquartered in New Orleans, recently received two government grants totaling $455,000.

Read Full Article

More News

Prediction

Correlation

Efficiency

News

AxoSim receives NIH grant...

Axosim hiring scientists